Skip to main content

News

New era of insights with release of survival by stage at diagnosis data for top five cancers

Cancer Australia has published an analysis of national data on survival by stage at diagnosis for the top five high incidence cancers – female breast, colorectal, lung, melanoma, and prostate.

Information on stage at diagnosis has now been combined with mortality data to examine how survival varies depending on the stage of cancer at diagnosis.

The release of the data on survival by stage at diagnosis marks a significant advance in the reporting of national cancer information.  The new data allows us to examine how survival varies depending on the stage of cancer at diagnosis, and to better understand differences across sociodemographic groups.

These national data are a result of Cancer Australia’s leadership and collaboration with all the state and territory population-based cancer registries and the Australian Institute of Health and Welfare.

The data can be accessed on Cancer Australia’s NCCI’s website, ncci.canceraustralia.gov.au and be filtered by tumour type and sociodemographic group.